Concepedia

Author

Fabio Turco

Università della Svizzera italianaORCID

Also Known As

F TURCO, F. Turco, Fabio TURCO, Fabio Turco, Turco, Fabio

75

Publications

993

Citations

16

H-Index

12

Concepts

All Affiliations

Università della Svizzera italianaUniversity of TurinCliniques Universitaires Saint-LucInstitut Gustave RoussyEnte Ospedaliero Cantonale
FT

About

Fabio Turco is an author at Università della Svizzera italiana specializing in medicine, orthopaedics, and bone health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

38

2

Health Sciences

1

1

17

3

Orthopaedics

1

1

21

4

Cancer Therapeutics

1

1

17

5

Clinical Trials

1

1

17

Fabio Turco

×

9

Publications

373

Citations

9

H-Index

YearCitations

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Silke Gillessen, Alberto Bossi, Ian D. Davis,

European Urology

2022

114

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Silke Gillessen, Fabio Turco, Ian D. Davis,

European Urology

2024

87

The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases the Postprandial Release of Cholecystokinin in Healthy Subjects

Paolo Andreozzi, Giovanni Sarnelli, Marcella Pesce,

Journal of Neurogastroenterology and Motility

2015

73

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study

Laura Marandino, Federica Trastu, Eleonora Ghisoni,

BMJ Oncology

2023

24

Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis

Silke Gillessen, Bertrand Tombal, Fabio Turco,

European Urology

2025

21

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study

Alessandro Rossi, Giacomo Aimar, Marco Audisio,

European Journal of Cancer

2023

17

EORTC 2238 “De-Escalate”: a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors

Guillaume Grisay, Fabio Turco, Saskia Litière,

Frontiers in Oncology

2024

15

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

Silke Gillessen, L.R. Murphy, Nicholas D. James,

The Lancet Oncology

2025

12

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)

Silke Gillessen, Giuseppe Procopio, Stefanie Hayoz,

Journal of Clinical Oncology

2023

10

Page 1